Cargando…
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
BACKGROUND: Selective registration, publication, and outcome reporting of clinical trials distort the primary clinical evidence that is available to patients and clinicians regarding the safety and efficacy of US Food and Drug Administration (FDA)-approved medical devices. The purpose of this study...
Autores principales: | Swanson, Matthew J., Johnston, James L., Ross, Joseph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597303/ https://www.ncbi.nlm.nih.gov/pubmed/34789308 http://dx.doi.org/10.1186/s13063-021-05790-9 |
Ejemplares similares
-
Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
por: Zou, Constance X., et al.
Publicado: (2018) -
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015) -
Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
por: Talebi, Ramtin, et al.
Publicado: (2020) -
Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016) -
Characteristics of pivotal clinical trials of FDA-approved endovascular devices between 2000 and 2018: An interrupted time series analysis
por: Moon, John T., et al.
Publicado: (2023)